In a closely decided ruling issued on June 24, 2013, the Supreme Court voted 5-4 that generic drug makers cannot be sued for adverse reactions to their products. This follows a 2011 ruling in which the Supreme Court decided that makers of generic drugs could not be sued for inadequate warnings as long as they were identical to the warnings on the brand name drugs.
According to the consumer ...
continue reading...